Establishment Labs Shares Climb on High Demand for FDA-Approved Breast Motiva Implants
First U.S. Women Successfully Receive Breast Augmentation With New FDA Approved Motiva Implants
Establishment Labs Is Maintained at Neutral by Citigroup
Establishment Labs Hldgs Analyst Ratings
Citi Maintains Establishment Labs(ESTA.US) With Hold Rating, Raises Target Price to $50
Express News | Establishment Labs Holdings Inc : Citigroup Raises Target Price to $50 From $45
Mizuho Securities Maintains Establishment Labs(ESTA.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Alkermes (ALKS) and Axsome Therapeutics (AXSM)
Express News | Establishment Labs Shares up 13.9% After Co Receives U.S. FDA Approval for Motiva Implants
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday
Traders Digest Fed's Preferred Inflation Metric as US Equity Futures Waver Pre-Bell
Jefferies Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $67
12 Health Care Stocks Moving In Friday's Pre-Market Session
Establishment Labs ESTA Implant Approval; EnVVeno NVNO Offering
Top Premarket Gainers
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $62
Establishment Labs: Strong Buy on FDA Approval and Market Expansion Potential
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Buy Rating Affirmed: Establishment Labs' Motiva Implant Poised to Disrupt the US Breast Implant Market
Establishment Labs Receives U.S. FDA Approval for Motiva Implants